c-Myc tag Peptide: Precision Tool for Immunoassays & Cancer Biology

Executive Summary: The c-Myc tag Peptide (SKU A6003) is a synthetic peptide corresponding to amino acids 410–419 of the human c-Myc protein, widely used for anti-c-Myc antibody binding inhibition in immunoassays (APExBIO product page). It plays a pivotal role in displacing c-Myc-tagged fusion proteins, allowing for the assessment of transcription factor regulation and proto-oncogenic pathways (3xflag.com). The peptide is highly soluble in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with ultrasonication) but insoluble in ethanol, with optimal storage at -20°C (Wu et al., 2021). c-Myc is a well-characterized proto-oncogene controlling cell proliferation, apoptosis, and differentiation (Fluoroorotic Acid Ultra Pure). This article provides atomic, machine-readable facts, with benchmarks and usage guidance for reproducible research.

Biological Rationale

The c-Myc protein is a transcription factor encoded by the MYC gene, essential for regulating cell proliferation, differentiation, apoptosis, and stem cell self-renewal (Wu et al., 2021). Dysregulation of c-Myc is implicated in tumorigenesis; overexpression can result in uncontrolled cell cycle progression and evasion of apoptosis. The c-Myc tag Peptide, derived from the C-terminal 410–419 amino acids of c-Myc, is routinely used as a molecular tool in biochemical assays and cancer biology research. By mimicking the native epitope, it enables specific competitive displacement of c-Myc-tagged proteins from anti-c-Myc antibodies, supporting precise immunoassay workflows (APExBIO).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide functions through competitive inhibition. It binds anti-c-Myc antibodies at the same epitope recognized on c-Myc-tagged fusion proteins, thereby displacing those proteins from antibody complexes. This mechanism is foundational for elution protocols in immunoprecipitation and affinity purification assays. Quantitatively, the peptide’s solubility profile ensures high working concentrations: ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (after ultrasonication), which is critical for experimental reproducibility (APExBIO). The peptide is insoluble in ethanol, which must be avoided to prevent precipitation and loss of function.

Evidence & Benchmarks

• The c-Myc tag Peptide displaces c-Myc-tagged fusion proteins from anti-c-Myc antibody complexes in immunoassays (3xflag.com).
• c-Myc activation upregulates cyclins and ribosomal proteins, while downregulating p21 and Bcl-2, supporting its proto-oncogenic function (Wu et al., 2021).
• The peptide is stable when desiccated at -20°C, but aqueous or DMSO solutions should not be stored long-term due to possible degradation (APExBIO).
• Experimental applications confirm high specificity for anti-c-Myc antibody binding inhibition, minimizing cross-reactivity (his6-tag.com).
• c-Myc is a validated model for transcription factor regulation studies, with direct implications in cancer and stem cell biology (fluoroorotic-acid-ultra-pure.com).

This article extends the mechanistic focus provided in "c-Myc tag Peptide: Precision Tool for Immunoassay & Cancer Biology" by detailing solubility, stability, and assay integration parameters. For workflow optimization strategies not covered here, see "Data-Driven Solutions for Cell Viability and Transcription Factor Studies", which benchmarks the A6003 kit in practical scenarios.

Applications, Limits & Misconceptions

Applications

• Elution of c-Myc-tagged fusion proteins in immunoprecipitation and affinity purification assays.
• Competitive inhibition assays for antibody specificity validation.
• Probing transcription factor regulation and oncogene function in cell and molecular biology.
• Standardization tool in multi-lab cancer biology research for reproducibility (his6-tag.com).

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not function as an inhibitor of endogenous c-Myc transcription factor activity in living cells; its use is limited to in vitro immunoassays.
• It is not suitable for diagnostic or therapeutic applications; the product is for research use only, as specified by APExBIO.
• Solubility is poor in ethanol; attempts to dissolve in ethanol will result in precipitation and loss of peptide.
• Long-term storage of peptide solutions (aqueous or DMSO) leads to degradation; always prepare fresh solutions before use.
• The peptide’s specificity is limited to anti-c-Myc antibodies targeting the 410–419 epitope; other antibodies may not be displaced.

Workflow Integration & Parameters

The c-Myc tag Peptide is typically reconstituted to ≥60.17 mg/mL in DMSO or ≥15.7 mg/mL in water with ultrasonic treatment. It is then added in molar excess to immunoprecipitation or affinity purification columns to competitively elute c-Myc-tagged fusion proteins. For best results, solutions should be freshly prepared and used immediately. Storage at -20°C in desiccated form ensures stability; avoid repeated freeze-thaw cycles. The peptide’s sequence (EQKLISEEDL) matches the c-Myc 410–419 region, which is recognized by most commercial anti-c-Myc antibodies. For detailed troubleshooting and protocol optimization, see "Mechanism, Applications, and Experimental Benchmarks". This article provides additional solubility and storage guidance not included in prior resources.

Conclusion & Outlook

The c-Myc tag Peptide from APExBIO (SKU A6003) is a validated, high-specificity reagent enabling displacement of c-Myc-tagged fusion proteins and robust anti-c-Myc antibody binding inhibition in immunoassays. Its well-defined sequence, reproducible solubility, and optimized storage parameters set a benchmark for research in transcription factor biology and cancer studies. While limited to in vitro applications, its role in standardizing assays and supporting mechanistic investigations is well established. Future developments may focus on expanding peptide tag technology for multiplexed protein interaction studies and advanced cell-based assays.